STOCK TITAN

Clearfield Financials

CLFD
FY2025 annual
Revenue $150.1M +19.6% YoY
Net Income -$8.1M +35.4% YoY
EPS (Diluted) -$0.58 +31.8% YoY
Free Cash Flow $21.8M +72.3% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE September

Clearfield (CLFD) reported $150.1M in revenue for fiscal year 2025, up 19.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CLFD FY2025

Clearfield’s cash generation is coming from working-capital release while margin recovery slowly rebuilds the income statement.

FY2025 operating cash flow of $26.6M coexisted with a net loss of -$8.1M, so cash was generated faster than earnings were repaired. That gap fits inventory dropping to $42.0M from $56.1M and lighter reinvestment, meaning the business harvested cash from a leaner balance sheet as sales recovered.

The sharpest operating change is in gross margin, which rebounded to 33.7% from 20.6%; that points to a normalization in cost or sales mix rather than a business still stuck in FY2024’s squeeze. But SG&A still absorbed almost all gross profit, leaving operating margin at only 1.4%, so the core business has improved faster than reported net income but is not yet back to its earlier earnings shape.

Even after share buybacks of $16.7M, Clearfield still held a current ratio of 5.4x, which indicates recovery is not being financed by heavy borrowing. The subtler shift is that liquidity is being normalized: the current ratio fell from 9.4x as excess working capital shrank, making the balance sheet less bloated while remaining conservative.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 52 / 100
Financial Health Score 52/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Clearfield's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
33

Clearfield has an operating margin of 1.4%, meaning the company retains $1 of operating profit per $100 of revenue. This results in a moderate score of 33/100, indicating healthy but not exceptional operating efficiency. This is up from -15.3% the prior year.

Growth
6

Clearfield's revenue surged 19.6% year-over-year to $150.1M, reflecting rapid business expansion. This strong growth earns a score of 6/100.

Leverage
74

Clearfield carries a low D/E ratio of 0.20, meaning only $0.20 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 74/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
91

With a current ratio of 5.42, Clearfield holds $5.42 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 91/100.

Cash Flow
70

Clearfield converts 14.5% of revenue into free cash flow ($21.8M). This strong cash generation earns a score of 70/100.

Returns
35

Clearfield posts a -3.1% return on equity (ROE), meaning it loses $3 for every $100 of shareholders' equity. This results in a returns score of 35/100. This is up from -4.5% the prior year.

Altman Z-Score Safe
6.18

Clearfield scores 6.18, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($378.9M) relative to total liabilities ($50.0M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Clearfield passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
N/A

Clearfield reported a net loss of $8.1M while generating $26.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$150.1M
YoY+19.6%
5Y CAGR+10.0%
10Y CAGR+9.5%

Clearfield generated $150.1M in revenue in fiscal year 2025. This represents an increase of 19.6% from the prior year.

EBITDA
$8.2M
YoY+161.9%
5Y CAGR-5.3%
10Y CAGR0.0%

Clearfield's EBITDA was $8.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 161.9% from the prior year.

Net Income
-$8.1M
YoY+35.4%

Clearfield reported -$8.1M in net income in fiscal year 2025. This represents an increase of 35.4% from the prior year.

EPS (Diluted)
-$0.58
YoY+31.8%

Clearfield earned -$0.58 per diluted share (EPS) in fiscal year 2025. This represents an increase of 31.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$21.8M
YoY+72.3%
5Y CAGR+35.1%
10Y CAGR+25.1%

Clearfield generated $21.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 72.3% from the prior year.

Cash & Debt
$21.5M
YoY+51.9%
5Y CAGR+5.5%
10Y CAGR+1.7%

Clearfield held $21.5M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
14M
YoY-3.1%
5Y CAGR+0.3%
10Y CAGR+0.1%

Clearfield had 14M shares outstanding in fiscal year 2025. This represents a decrease of 3.1% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
33.7%
YoY+13.1pp
5Y CAGR-7.1pp
10Y CAGR-7.6pp

Clearfield's gross margin was 33.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 13.1 percentage points from the prior year.

Operating Margin
1.4%
YoY+16.7pp
5Y CAGR-7.6pp
10Y CAGR-10.3pp

Clearfield's operating margin was 1.4% in fiscal year 2025, reflecting core business profitability. This is up 16.7 percentage points from the prior year.

Net Margin
-5.4%
YoY+4.6pp
5Y CAGR-13.2pp
10Y CAGR-13.1pp

Clearfield's net profit margin was -5.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 4.6 percentage points from the prior year.

Return on Equity
-3.1%
YoY+1.4pp
5Y CAGR-11.9pp
10Y CAGR-12.3pp

Clearfield's ROE was -3.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.4 percentage points from the prior year.

Capital Allocation

R&D Spending
$2.4M
YoY-19.3%
5Y CAGR+13.8%
10Y CAGR+12.4%

Clearfield invested $2.4M in research and development in fiscal year 2025. This represents a decrease of 19.3% from the prior year.

Share Buybacks
$16.7M
YoY-50.1%
5Y CAGR+107.9%

Clearfield spent $16.7M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 50.1% from the prior year.

Capital Expenditures
$4.7M
YoY-50.4%
5Y CAGR+21.3%
10Y CAGR+0.5%

Clearfield invested $4.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 50.4% from the prior year.

CLFD Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CLFD annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$153.7M$150.1M+19.6%$125.6M-44.4%$225.7M-16.7%$270.9M+92.5%$140.8M+51.2%$93.1M+9.5%$85.0M+9.5%$77.7M+5.0%$73.9M-1.8%$75.3M+24.8%$60.3M+3.9%$58.0M+8.8%$53.4M+42.4%$37.5M+6.5%$35.2M
Cost of Revenue$102.9M$99.6M-0.1%$99.7M-31.6%$145.9M-7.6%$157.9M+98.5%$79.6M+44.3%$55.2M+5.4%$52.3M+12.2%$46.7M+6.8%$43.7M+3.0%$42.4M+19.6%$35.5M+6.0%$33.4M+6.6%$31.4M+41.4%$22.2M+8.1%$20.5M
Gross Profit$50.7M$50.5M+95.5%$25.8M-67.6%$79.9M-29.3%$112.9M+84.6%$61.2M+61.4%$37.9M+16.0%$32.7M+5.5%$31.0M+2.4%$30.3M-7.9%$32.9M+32.2%$24.9M+1.1%$24.6M+11.9%$22.0M+43.9%$15.3M+4.3%$14.7M
R&D ExpensesN/A$2.4M-19.3%$3.0M-3.7%$3.1M+248.0%$895K+268.3%$243K-80.8%$1.3M+16.3%$1.1M+38.4%$787K-9.0%$866K+3.3%$838K+11.7%$750K+6.6%$704KN/AN/AN/A
SG&A Expenses$51.1M$48.4M+7.4%$45.1M+6.6%$42.3M-13.9%$49.1M+36.7%$35.9M+21.7%$29.5M+7.4%$27.5M+6.1%$25.9M+3.9%$25.0M+12.7%$22.1M+24.3%$17.8M+10.8%$16.1M+10.6%$14.5M+32.1%$11.0M+0.2%$11.0M
Operating Income-$367K$2.1M+111.0%-$19.2M-151.2%$37.6M-41.1%$63.8M+152.9%$25.2M+201.0%$8.4M+61.6%$5.2M+2.3%$5.1M-4.5%$5.3M-50.5%$10.7M+52.2%$7.1M-17.2%$8.5M+14.4%$7.4M+74.2%$4.3M+15.0%$3.7M
Interest ExpenseN/AN/A$506K-42.6%$881K+183.3%$311KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax$1.6M$2.4M+172.6%-$3.2M-136.6%$8.9M-38.6%$14.5M+167.7%$5.4M+190.4%$1.9M+36.9%$1.4M+8.5%$1.3M-27.9%$1.7M-39.6%$2.9M+16.2%$2.5M-22.2%$3.2M+13.5%$2.8M+184.3%-$3.3M-43.5%-$2.3M
Net Income-$7.2M-$8.1M+35.4%-$12.5M-138.3%$32.5M-34.1%$49.4M+142.8%$20.3M+178.7%$7.3M+59.7%$4.6M+6.8%$4.3M+11.1%$3.8M-52.0%$8.0M+71.1%$4.7M-13.8%$5.4M+14.8%$4.7M-38.5%$7.7M+24.9%$6.2M
EPS (Diluted)-$0.58+31.8%-$0.85-139.2%$2.17-38.9%$3.55+141.5%$1.47+177.4%$0.53+55.9%$0.34+6.3%$0.32+14.3%$0.28-52.5%$0.59+73.5%$0.34-15.0%$0.40+11.1%$0.36-40.0%$0.60+25.0%$0.48

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CLFD Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CLFD annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$306.2M-2.9%$315.3M-11.3%$355.5M+55.2%$229.1M+82.0%$125.9M+32.1%$95.3M+16.4%$81.9M+10.3%$74.2M+6.8%$69.5M-1.6%$70.6M+22.5%$57.6M+11.1%$51.8M+11.7%$46.4M+23.0%$37.7M+24.5%$30.3M
Current Assets$198.5M-13.5%$229.6M-22.5%$296.3M+85.0%$160.1M+123.9%$71.5M+36.1%$52.5M+23.6%$42.5M+3.4%$41.1M-0.1%$41.1M-19.5%$51.1M+25.4%$40.8M+7.1%$38.0M+11.2%$34.2M+50.4%$22.7M+12.2%$20.3M
Cash & Equivalents$21.5M+51.9%$14.1M-62.6%$37.8M+127.2%$16.6M+26.0%$13.2M-19.7%$16.4M+63.2%$10.1M+17.9%$8.5M-53.9%$18.5M-33.8%$28.0M+55.0%$18.1M-0.7%$18.2M+85.5%$9.8M+72.7%$5.7M-49.7%$11.3M
Inventory$42.0M-25.1%$56.1M-42.8%$98.1M+19.3%$82.2M+198.7%$27.5M+91.0%$14.4M+59.9%$9.0M-10.3%$10.1M+18.9%$8.5M+1.0%$8.4M+16.6%$7.2M+33.3%$5.4M-4.2%$5.6M+89.4%$3.0M+7.8%$2.8M
Accounts Receivable$18.0M+30.0%$13.8M-51.2%$28.4M-47.1%$53.7M+176.3%$19.4M+85.2%$10.5M+15.1%$9.1M-28.9%$12.8M+77.1%$7.2M-9.5%$8.0M+33.1%$6.0M+19.6%$5.0M-35.8%$7.8M+159.3%$3.0M-6.4%$3.2M
Goodwill$4.7M-28.9%$6.6M+1.5%$6.5M+2.0%$6.4M+36.0%$4.7M0.0%$4.7M0.0%$4.7M0.0%$4.7M+83.2%$2.6M0.0%$2.6M0.0%$2.6M0.0%$2.6M0.0%$2.6M0.0%$2.6M0.0%$2.6M
Total Liabilities$50.0M+26.6%$39.5M-2.1%$40.4M-50.5%$81.5M+269.2%$22.1M+76.1%$12.5M+80.4%$7.0M+29.9%$5.4M+7.7%$5.0M-37.9%$8.0M+26.0%$6.3M+24.4%$5.1M-19.5%$6.3M+107.4%$3.1M-25.0%$4.1M
Current Liabilities$36.6M+50.3%$24.4M-16.0%$29.0M-43.9%$51.7M+152.5%$20.5M+96.6%$10.4M+57.6%$6.6M+32.7%$5.0M+17.4%$4.2M-42.2%$7.3M+45.8%$5.0M-1.3%$5.1M-19.2%$6.3M+109.3%$3.0M-24.8%$4.0M
Long-Term DebtN/A$2.2M$0-100.0%$18.7M$0N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Equity$256.2M-7.1%$275.8M-12.5%$315.2M+113.6%$147.6M+42.1%$103.8M+25.5%$82.8M+10.4%$74.9M+8.8%$68.9M+6.7%$64.5M+3.1%$62.6M+22.1%$51.3M+9.7%$46.7M+16.6%$40.1M+15.5%$34.7M+32.2%$26.2M
Retained Earnings$106.9M-7.0%$115.0M-9.7%$127.3M+34.3%$94.8M+108.6%$45.4M+80.9%$25.1M+40.9%$17.8M+34.4%$13.3M+47.6%$9.0M+75.0%$5.1M+208.1%-$4.7M+49.7%-$9.4M+36.6%-$14.9M+24.2%-$19.6M+28.2%-$27.3M

CLFD Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

CLFD annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$11.5M$26.6M+19.5%$22.2M+20.6%$18.4M+715.9%$2.3M-79.3%$10.9M+63.8%$6.7M-54.8%$14.7M+224.0%$4.5M-27.8%$6.3M-45.5%$11.6M+68.7%$6.8M-40.6%$11.5M+165.7%$4.3M+13.4%$3.8M-27.8%$5.3M
Capital Expenditures$4.1M$4.7M-50.4%$9.6M+24.5%$7.7M-9.6%$8.5M+315.4%$2.0M+13.3%$1.8M-28.1%$2.5M+111.1%$1.2M-41.1%$2.0M+30.4%$1.6M-65.7%$4.5M+218.6%$1.4M+39.3%$1.0M+85.0%$551K-26.2%$746K
Free Cash Flow$7.3M$21.8M+72.3%$12.7M+17.8%$10.7M+272.1%-$6.2M-170.5%$8.9M+82.6%$4.8M-60.3%$12.2M+264.0%$3.4M-21.5%$4.3M-57.2%$10.0M+329.4%$2.3M-77.0%$10.1M+204.5%$3.3M+1.4%$3.3M-28.0%$4.6M
Investing Cash FlowN/AN/A-$6.9M+93.9%-$112.2M-1269.4%-$8.2M+39.7%-$13.6M-33070.7%-$41K+99.7%-$13.0M-2.8%-$12.6M-9.3%-$11.5M-602.9%-$1.6M+71.4%-$5.7M-60.2%-$3.6M-3051.1%-$114K+98.8%-$9.7M-2425.2%$418K
Financing Cash FlowN/AN/A-$36.9M-132.1%$115.0M+1123.8%$9.4M+1853.2%-$536K-117.0%-$247K-4.4%-$237K+87.7%-$1.9M+54.5%-$4.2M-13351.4%$32K+102.6%-$1.2M-377.7%$441K+562.0%-$95K-133.5%$285K+1.6%$280K
Share Buybacks$13.5M$16.7M-50.1%$33.4M$0$0$0-100.0%$429KN/A$1.8M-51.7%$3.6M+992.8%$334K-60.7%$849KN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid.

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

CLFD Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

CLFD annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin33.7%+13.1pp20.6%-14.8pp35.4%-6.3pp41.7%-1.8pp43.5%+2.7pp40.7%+2.3pp38.4%-1.5pp39.9%-1.0pp40.9%-2.7pp43.7%+2.4pp41.2%-1.2pp42.4%+1.2pp41.2%+0.4pp40.8%-0.9pp41.6%
Operating Margin1.4%+16.7pp-15.3%-32.0pp16.7%-6.9pp23.6%+5.6pp17.9%+8.9pp9.0%+2.9pp6.1%-0.4pp6.5%-0.7pp7.2%-7.1pp14.2%+2.6pp11.7%-3.0pp14.7%+0.7pp14.0%+2.5pp11.4%+0.8pp10.6%
Net Margin-5.4%+4.6pp-9.9%-24.3pp14.4%-3.8pp18.2%+3.8pp14.4%+6.6pp7.8%+2.5pp5.4%-0.1pp5.5%+0.3pp5.2%-5.4pp10.6%+2.9pp7.8%-1.6pp9.4%+0.5pp8.9%-11.7pp20.5%+3.0pp17.5%
Return on Equity-3.1%+1.4pp-4.5%-14.8pp10.3%-23.1pp33.5%+13.9pp19.6%+10.8pp8.8%+2.7pp6.1%-0.1pp6.2%+0.3pp6.0%-6.8pp12.8%+3.7pp9.1%-2.5pp11.6%-0.2pp11.8%-10.4pp22.2%-1.3pp23.5%
Return on Assets-2.6%+1.3pp-4.0%-13.1pp9.2%-12.4pp21.5%+5.4pp16.1%+8.5pp7.6%+2.1pp5.6%-0.2pp5.8%+0.2pp5.5%-5.8pp11.3%+3.2pp8.1%-2.4pp10.5%+0.3pp10.2%-10.2pp20.4%+0.1pp20.3%
Current Ratio5.42-4.0x9.43-0.8x10.21+7.1x3.10-0.4x3.49-1.6x5.04-1.4x6.43-1.8x8.25-1.4x9.70+2.7x6.96-1.1x8.09+0.6x7.46+2.0x5.42-2.1x7.54+2.5x5.06
Debt-to-Equity0.20+0.2x0.010.0x0.00-0.1x0.13+0.1x0.00-0.2x0.15+0.1x0.090.0x0.080.0x0.08-0.1x0.130.0x0.120.0x0.110.0x0.16+0.1x0.09-0.1x0.16
FCF Margin14.5%+4.5pp10.1%+5.3pp4.8%+7.1pp-2.3%-8.6pp6.3%+1.1pp5.2%-9.2pp14.4%+10.0pp4.3%-1.5pp5.8%-7.5pp13.3%+9.4pp3.9%-13.6pp17.4%+11.2pp6.2%-2.5pp8.7%-4.2pp12.9%

Similar Companies

Frequently Asked Questions

What is Clearfield's annual revenue?

Clearfield (CLFD) reported $150.1M in total revenue for fiscal year 2025. This represents a 19.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Clearfield's revenue growing?

Clearfield (CLFD) revenue grew by 19.6% year-over-year, from $125.6M to $150.1M in fiscal year 2025.

Is Clearfield profitable?

No, Clearfield (CLFD) reported a net income of -$8.1M in fiscal year 2025, with a net profit margin of -5.4%.

Clearfield (CLFD) reported diluted earnings per share of -$0.58 for fiscal year 2025. This represents a 31.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Clearfield (CLFD) had EBITDA of $8.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Clearfield (CLFD) had a gross margin of 33.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Clearfield (CLFD) had an operating margin of 1.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Clearfield (CLFD) had a net profit margin of -5.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Clearfield (CLFD) has a return on equity of -3.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Clearfield (CLFD) generated $21.8M in free cash flow during fiscal year 2025. This represents a 72.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Clearfield (CLFD) generated $26.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Clearfield (CLFD) had $306.2M in total assets as of fiscal year 2025, including both current and long-term assets.

Clearfield (CLFD) invested $4.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Clearfield (CLFD) invested $2.4M in research and development during fiscal year 2025.

Yes, Clearfield (CLFD) spent $16.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Clearfield (CLFD) had 14M shares outstanding as of fiscal year 2025.

Clearfield (CLFD) had a current ratio of 5.42 as of fiscal year 2025, which is generally considered healthy.

Clearfield (CLFD) had a debt-to-equity ratio of 0.20 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Clearfield (CLFD) had a return on assets of -2.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Clearfield (CLFD) has an Altman Z-Score of 6.18, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Clearfield (CLFD) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Clearfield (CLFD) reported a net loss of $8.1M while generating $26.6M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Clearfield (CLFD) scores 52 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top